Ligand Pharmaceuticals Inc - Insider Trading & Ownership

Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
Summary
The estimated value of insider holdings of Ligand Pharmaceuticals Inc is at least $15M dollars as of November 10, 2025. Ligand Pharmaceuticals Inc is the Director, 10%+ Owner of Pelthos Therapeutics Inc. and owns shares of Channel Therapeutics Corp (CHRO) stock worth about $15M.
Signature
/s/ Octavio Espinoza, Chief Financial Officer of Ligand Pharmaceuticals Incorporated
All Insider Reports
All Insider Reports

Ownership of Ligand Pharmaceuticals Inc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CHRO Channel Therapeutics Corp Director, 10%+ Owner $15M Nov 6, 2025
NONE OmniAb Operations, Inc. 10%+ Owner Nov 1, 2022

Insider Transactions Reported by Ligand Pharmaceuticals Inc:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.